Drug Discovery

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

How unified assay protocols and advanced bioinformatics are refining our understanding of mitochondrial dysfunction in complex diseases.

What lies ahead for the future of pharma? Dennis van Rooji gives his view.

Proprietary nanovesicles technology has caught the eye of Eli Lilly. We find out why.

What happens when freezers fail? Experts look at the lessons that can be learned from catastrophic power outages.

Immunotherapies can accomplish much, but we can only unlock their true power through collaboration.

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

How to meet the demand for first-in-human clinical trials using fit-for-phase formulation approaches.

Find out more about a new continuous manufacturing facility opened by Just – Evotec Biologics in Toulouse, France.

How immunotherapy could redefine cancer treatment.